GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CMIC HOLDINGS Co Ltd (TSE:2309) » Definitions » EV-to-EBITDA

CMIC HOLDINGS Co (TSE:2309) EV-to-EBITDA : 4.00 (As of May. 16, 2024)


View and export this data going back to 2002. Start your Free Trial

What is CMIC HOLDINGS Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CMIC HOLDINGS Co's enterprise value is 円36,522 Mil. CMIC HOLDINGS Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円9,120 Mil. Therefore, CMIC HOLDINGS Co's EV-to-EBITDA for today is 4.00.

The historical rank and industry rank for CMIC HOLDINGS Co's EV-to-EBITDA or its related term are showing as below:

TSE:2309' s EV-to-EBITDA Range Over the Past 10 Years
Min: -0.81   Med: 13.43   Max: 10569587.25
Current: -0.81

During the past 13 years, the highest EV-to-EBITDA of CMIC HOLDINGS Co was 10569587.25. The lowest was -0.81. And the median was 13.43.

TSE:2309's EV-to-EBITDA is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 16.395 vs TSE:2309: -0.81

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), CMIC HOLDINGS Co's stock price is 円2632.00. CMIC HOLDINGS Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円307.986. Therefore, CMIC HOLDINGS Co's PE Ratio for today is 8.55.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


CMIC HOLDINGS Co EV-to-EBITDA Historical Data

The historical data trend for CMIC HOLDINGS Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CMIC HOLDINGS Co EV-to-EBITDA Chart

CMIC HOLDINGS Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.55 7.03 5.34 2.60 0.88

CMIC HOLDINGS Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.32 2.98 1.66 0.88 4.02

Competitive Comparison of CMIC HOLDINGS Co's EV-to-EBITDA

For the Diagnostics & Research subindustry, CMIC HOLDINGS Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CMIC HOLDINGS Co's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CMIC HOLDINGS Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CMIC HOLDINGS Co's EV-to-EBITDA falls into.



CMIC HOLDINGS Co EV-to-EBITDA Calculation

CMIC HOLDINGS Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=36522.160/9120
=4.00

CMIC HOLDINGS Co's current Enterprise Value is 円36,522 Mil.
CMIC HOLDINGS Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円9,120 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CMIC HOLDINGS Co  (TSE:2309) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CMIC HOLDINGS Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2632.00/307.986
=8.55

CMIC HOLDINGS Co's share price for today is 円2632.00.
CMIC HOLDINGS Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円307.986.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


CMIC HOLDINGS Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CMIC HOLDINGS Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CMIC HOLDINGS Co (TSE:2309) Business Description

Traded in Other Exchanges
N/A
Address
Hamamatsucho Building, 1-1-1 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
CMIC HOLDINGS Co Ltd is a Japan-based management consulting company. It contributes to the development of the medical and healthcare field. The company is mainly engaged in Contract Research Organization (CRO), Contract Development and Manufacturing (CDMO), Contract Sales Organization (CSO), Innovative Pharma Model (IPM) and healthcare business. CMIC support a wide range of pharmaceutical management services such as data management, statistical analysis, medicine consulting, medical writing, audit, and analytical tests, clinical trials for the medical and pharmaceutical industry, human resource services. It is also engaged in providing sales and marketing support for pharmaceuticals.

CMIC HOLDINGS Co (TSE:2309) Headlines

No Headlines